iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses

European Journal of Immunology

Volumn 44, Issue 8, 2014, Pages 2230-2237

  Dellabona, Paolo ^a   Abrignani, Sergio ^b   Casorati, Giulia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

B cell help; CD1d; T follicular helper cells; Vaccines

Indexed keywords

ANTIGEN; CD1D ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G ANTIBODY;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; INNATE IMMUNITY; INVARIANT NATURAL KILLER T; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

B-CELL HELP; CD1D; T FOLLICULAR HELPER CELLS; VACCINES;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS; B-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNITY, INNATE; NATURAL KILLER T-CELLS;

EID: 84906090746     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344399     Document Type: Review

References (67)

1. Germain, R. N., Vaccines and the future of human immunology. Immunity 2010. 33: 441-450.
2. Bendelac, A., Bonneville, M. and Kearney, J. F., Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 2001. 1: 177-186.
3. Salio, M., Silk, J. D., Jones, E. Y. and Cerundolo, V., Biology of CD1- and MR1-Restricted T Cells. Annu. Rev. Immunol. 2014. 32: 323-366.
4. Vinuesa, C. G., Tangye, S. G., Moser, B. and Mackay, C. R., Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 2005. 5: 853-865.
5. Cyster, J. G., B cell follicles and antigen encounters of the third kind. Nature immunology 2010. 11: 989-996.
6. Ma, C. S., Deenick, E. K., Batten, M. and Tangye, S. G., The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 2012. 209: 1241-1253.
7. Pape, K. A., Kouskoff, V., Nemazee, D., Tang, H. L., Cyster, J. G., Tze, L. E., Hippen, K. L. et al., Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J. Exp. Med. 2003. 197: 1677-1687.
8. MacLennan, I. C., Germinal centers. Annu. Rev. Immunol. 1994. 12: 117-139.
9. McHeyzer-Williams, L. J. and McHeyzer-Williams, M. G., Antigen-specific memory B cell development. Annu. Rev. Immunol. 2005. 23: 487-513.
10. Mond, J. J., Lees, A. and Snapper, C. M., T cell-independent antigens type 2. Annu. Rev. Immunol. 1995. 13: 655-692.
11. Obukhanych, T. V. and Nussenzweig, M. C., T-independent type II immune responses generate memory B cells. J. Exp. Med. 2006. 203: 305-310.
12. Dellabona, P., Padovan, E., Casorati, G., Brockhaus, M. and Lanzavecchia, A., An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 1994. 180: 1171-1176.
13. Lantz, O. and Bendelac, A., An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J. Exp. Med. 1994. 180: 1097-1106.
14. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R. and Brutkiewicz, R. R., CD1 recognition by mouse NK1+ T lymphocytes. Science 1995. 268: 863-865.
15. Dougan, S. K., Kaser, A. and Blumberg, R. S., CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 2007. 314: 113-141.
16. Tupin, E., Kinjo, Y. and Kronenberg, M., The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007. 5: 405-417.
17. Kinjo, Y., Illarionov, P., Vela, J. L., Pei, B., Girardi, E., Li, X., Li, Y. et al., Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat. Immunol. 2011. 12: 966-974.
18. Albacker, L. A., Chaudhary, V., Chang, Y. J., Kim, H. Y., Chuang, Y. T., Pichavant, M., DeKruyff, R. H. et al., Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat. Med. 2013. 19: 1297-1304.
19. Brennan, P. J., Brigl, M. and Brenner, M. B., Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 2013. 13: 101-117.
20. Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. and Hogquist, K. A., Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 2013. 14: 1146-1154.
21. Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M. et al., The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 1999. 189: 1121-1128.
22. Arora, P., Baena, A., Yu, K. O., Saini, N. K., Kharkwal, S. S., Goldberg, M. F., Kunnath-Velayudhan, S. et al., A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity 2014. 40: 105-116.
23. Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y. and Bendelac, A., Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999. 163: 4647-4650.
24. Hermans, I. F., Silk, J. D., Gileadi, U., Salio, M., Mathew, B., Ritter, G., Schmidt, R. et al., NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 2003. 171: 5140-5147.
25. Gonzalez-Aseguinolaza, G., Van Kaer, L., Bergmann, C. C., Wilson, J. M., Schmieg, J., Kronenberg, M., Nakayama, T. et al., Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 2002. 195: 617-624.
26. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. and Steinman, R. M., Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003. 198: 267-279.
27. Brossay, L., Jullien, D., Cardell, S., Sydora, B. C., Burdin, N., Modlin, R. L. and Kronenberg, M., Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 1997. 159: 1216-1224.
28. Exley, M., Garcia, J., Wilson, S. B., Spada, F., Gerdes, D., Tahir, S. M., Patton, K. T. et al., CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000. 100: 37-47.
29. Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y. et al., Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 1999. 163: 2373-2377.
30. Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J. and Tachado, S. D., CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999. 283: 225-229.
31. Molano, A., Park, S. H., Chiu, Y. H., Nosseir, S., Bendelac, A. and Tsuji, M., Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 2000. 164: 5005-5009.
32. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. et al., CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 2003. 197: 1051-1057.
33. Ko, S. Y., Ko, H. J., Chang, W. S., Park, S. H., Kweon, M. N. and Kang, C. Y., alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 2005. 175: 3309-3317.
34. Lang, G. A., Exley, M. A. and Lang, M. L., The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 2006. 119: 116-125.
35. Galli, G., Pittoni, P., Tonti, E., Malzone, C., Uematsu, Y., Tortoli, M., Maione, D. et al., Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. USA 2007. 104: 3984-3989.
36. Devera, T. S., Shah, H. B., Lang, G. A. and Lang, M. L., Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur. J. Immunol. 2008. 38: 1001-1011.
37. Shah, H. B., Joshi, S. K., Rampuria, P., Devera, T. S., Lang, G. A., Stohl, W. and Lang, M. L., BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J. Immunol. 2013. 191: 1154-1163.
38. Tonti, E., Galli, G., Malzone, C., Abrignani, S., Casorati, G. and Dellabona, P., NKT-cell help to B lymphocytes can occur independently of cognate interaction. Blood 2009. 113: 370-376.
39. Scanlon, S. T., Thomas, S. Y., Ferreira, C. M., Bai, L., Krausz, T., Savage, P. B. and Bendelac, A., Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J. Exp. Med. 2011. 208: 2113-2124.
40. Detre, C., Keszei, M., Garrido-Mesa, N., Kis-Toth, K., Castro, W., Agyemang, A. F., Veerapen, N. et al., SAP expression in invariant NKT cells is required for cognate help to support B-cell responses. Blood 2012. 120: 122-129.
41. Thomas, S. Y., Scanlon, S. T., Griewank, K. G., Constantinides, M. G., Savage, A. K., Barr, K. A., Meng, F. et al., PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 2011. 208: 1179-1188.
42. Barral, P., Sanchez-Nino, M. D., van Rooijen, N., Cerundolo, V. and Batista, F. D., The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012. 31: 2378-2390.
43. King, I. L., Amiel, E., Tighe, M., Mohrs, K., Veerapen, N., Besra, G., Mohrs, M. et al., The mechanism of splenic invariant NKT cell activation dictates localization in vivo. J. Immunol. 2013. 191: 572-582.
44. Kastenmuller, W., Torabi-Parizi, P., Subramanian, N., Lammermann, T. and Germain, R. N., A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012. 150: 1235-1248.
45. Barral, P., Polzella, P., Bruckbauer, A., van Rooijen, N., Besra, G. S., Cerundolo, V. and Batista, F. D., CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat. Immunol. 2010. 11: 303-312.
46. Youn, H. J., Ko, S. Y., Lee, K. A., Ko, H. J., Lee, Y. S., Fujihashi, K., Boyaka, P. N. et al., A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 2007. 25: 5189-5198.
47. Kopecky-Bromberg, S. A., Fraser, K. A., Pica, N., Carnero, E., Moran, T. M., Franck, R. W., Tsuji, M. et al., Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 2009. 27: 3766-3774.
48. Devera, T. S., Aye, L. M., Lang, G. A., Joshi, S. K., Ballard, J. D. and Lang, M. L., CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies. Infect. Immun. 2010. 78: 1610-1617.
49. Kamijuku, H., Nagata, Y., Jiang, X., Ichinohe, T., Tashiro, T., Mori, K., Taniguchi, M. et al., Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 2008. 1: 208-218.
50. Leadbetter, E. A., Brigl, M., Illarionov, P., Cohen, N., Luteran, M. C., Pillai, S., Besra, G. S. et al., NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Natl. Acad. Sci. USA 2008. 105: 8339-8344.
51. Barral, P., Eckl-Dorna, J., Harwood, N. E., De Santo, C., Salio, M., Illarionov, P., Besra, G. S. et al., B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl. Acad. Sci. USA 2008. 105: 8345-8350.
52. Mattner, J., Savage, P. B., Leung, P., Oertelt, S. S., Wang, V., Trivedi, O., Scanlon, S. T. et al., Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008. 3: 304-315.
53. Allan, L. L., Hoefl, K., Zheng, D. J., Chung, B. K., Kozak, F. K., Tan, R. and van den Elzen, P., Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009. 114: 2411-2416.
54. Chang, P. P., Barral, P., Fitch, J., Pratama, A., Ma, C. S., Kallies, A., Hogan, J. J. et al., Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 2012. 13: 35-43.
55. Tonti, E., Fedeli, M., Napolitano, A., Iannacone, M., von Andrian, U. H., Guidotti, L. G., Abrignani, S. et al., Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help. J. Immunol. 2012. 188: 3217-3222.
56. King, I. L., Fortier, A., Tighe, M., Dibble, J., Watts, G. F., Veerapen, N., Haberman, A. M. et al., Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat. Immunol. 2011. 13: 44-50.
57. Linterman, M. A., Pierson, W., Lee, S. K., Kallies, A., Kawamoto, S., Rayner, T. F., Srivastava, M. et al., Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 2011. 17: 975-982.
58. Chung, Y., Tanaka, S., Chu, F., Nurieva, R. I., Martinez, G. J., Rawal, S., Wang, Y. H. et al., Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 2011. 17: 983-988.
59. Lang, G. A., Devera, T. S. and Lang, M. L., Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 2008. 111: 2158-2162.
60. Shah, H. B., Joshi, S. K. and Lang, M. L., CD40L-null NKT cells provide B cell help for specific antibody responses. Vaccine 2011. 29: 9132-9136.
61. Joshi, S. K., Lang, G. A., Devera, T. S., Johnson, A. M., Kovats, S. and Lang, M. L., Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation. J. Leukoc. Biol. 2012. 91: 783-790.
62. Linterman, M. A., Liston, A. and Vinuesa, C. G., T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells. Immunol. Rev. 2012. 247: 143-159.
63. Bai, L., Deng, S., Reboulet, R., Mathew, R., Teyton, L., Savage, P. B. and Bendelac, A., Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc. Natl. Acad. Sci. USA 2013. 110: 16097-16102.
64. MacLennan, I. C., Toellner, K. M., Cunningham, A. F., Serre, K., Sze, D. M., Zuniga, E., Cook, M. C. et al., Extrafollicular antibody responses. Immunol. Rev. 2003. 194: 8-18.
65. Wen, X., Yang, J. Q., Kim, P. J. and Singh, R. R., Homeostatic regulation of marginal zone B cells by invariant natural killer T cells. PLoS One 2011. 6: e26536.
66. Richter, J., Neparidze, N., Zhang, L., Nair, S., Monesmith, T., Sundaram, R., Miesowicz, F. et al., Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood 2013. 121: 423-430.
67. Motohashi, S., Nagato, K., Kunii, N., Yamamoto, H., Yamasaki, K., Okita, K., Hanaoka, H. et al., A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J. Immunol. 2009. 182: 2492-2501.